DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Molbio Diagnostics Limited — Analyst/Investor Meet Para A-XBRL

NSE 2 hrs ago·17 Sept 2026, 9:55 am

Molbio Diagnostics

Molbio Diagnostics Limited has informed the stock exchanges about an upcoming meeting with analysts and institutional investors. The company has filed a formal announcement detailing the schedule for this interaction.

This disclosure is a standard corporate practice that signals management's willingness to engage with the investment community. For investors, such meetings often provide a platform for the company to discuss its financial performance, future strategy, and address specific queries from the market.

Investors should watch for any specific topics the management chooses to highlight during this session. This information can offer valuable insights into the company's outlook and help investors assess the current sentiment surrounding the stock.